« Previous
Next »
Subjects
- COVID-19 Drug Treatment[remove]14
- United States14
- United States. Department of Health and Human Services6
- United States. Food and Drug Administration6
- Biological Products3
- COVID-19 -- prevention & control3
- COVID-19 Vaccines -- economics3
- Drug Approval3
- Drug Industry3
- Antibodies, Monoclonal2
- COVID-19 -- economics2
- Cost Savings2
- Drugs, Investigational2
- SARS-CoV-22
- Ambulatory Care1
- Ambulatory Care -- economics1
- Antibodies, Monoclonal, Humanized -- therapeutic use1
- Antiviral Agents -- economics1
- Antiviral Agents -- therapeutic use1
- Biological Products -- therapeutic use1